Co-Crystallization Approach to Enhance the Stability of Moisture-Sensitive Drugs
Pharmaceutics · 05.01.2023 · 15 (1) · 189
DOI: 10.3390/pharmaceutics15010189 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 05.01.2023. Verfasst von Madhukiran R Dhondale und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Engineering and Technology, Indian Institute of Technology (BHU), Varanasi 221005, India. Die Arbeit wurde bisher 76-mal zitiert (Crossref) und nennt 112 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: PMRF, India, SERB, India.
Abstract (Originalsprache)
Stability is an essential quality attribute of any pharmaceutical formulation. Poor stability can change the color and physical appearance of a drug, directly impacting the patient’s perception. Unstable drug products may also face loss of active pharmaceutical ingredients (APIs) and degradation, making the medicine ineffective and toxic. Moisture content is known to be the leading cause of the degradation of nearly 50% of medicinal products, leading to impurities in solid dose formulations. The polarity of the atoms in an API and the surface chemistry of API particles majorly influence the affinity towards water molecules. Moisture induces chemical reactions, including free water that has also been identified as an important factor in determining drug product stability. Among the various approaches, crystal engineering and specifically co-crystals, have a proven ability to increase the stability of moisture-sensitive APIs. Other approaches, such as changing the salt form, can lead to solubility issues, thus making the co-crystal approach more suited to enhancing hygroscopic stability. There are many reported studies where co-crystals have exhibited reduced hygroscopicity compared to pure API, thereby improving the product’s stability. In this review, the authors focus on recent updates and trends in these studies related to improving the hygroscopic stability of compounds, discuss the reasons behind the enhanced stability, and briefly discuss the screening of co-formers for moisture-sensitive drugs.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmaceutical Engineering and Technology, Indian Institute of Technology (BHU), Varanasi 221005, India.
- Natco Research Center, Natco Pharma Limited, Hyderabad 500018, India.
- Solid State Pharmaceutical Research, Hyderabad 500037, India.
ORCID-Profile: Amritha G Nambiar, Maan Singh, Ashish K Agrawal, Dinesh Kumar
Förderung
- PMRF, India
- SERB, India
Zitieren
APA
Dhondale, M. R., Thakor, P., Nambiar, A. G., Singh, M., Agrawal, A. K., Shastri, N. R., & Kumar, D. (2023). Co-Crystallization Approach to Enhance the Stability of Moisture-Sensitive Drugs. Pharmaceutics, 15(1), 189. https://doi.org/10.3390/pharmaceutics15010189
Vancouver
Dhondale MR, Thakor P, Nambiar AG, Singh M, Agrawal AK, Shastri NR, et al. Co-Crystallization Approach to Enhance the Stability of Moisture-Sensitive Drugs. Pharmaceutics. 2023;15(1):189. doi:10.3390/pharmaceutics15010189
BibTeX
@article{Dhondale2023,
author = {Dhondale, Madhukiran R and Thakor, Pradip and Nambiar, Amritha G and Singh, Maan and Agrawal, Ashish K and Shastri, Nalini R and Kumar, Dinesh},
title = {Co-Crystallization Approach to Enhance the Stability of Moisture-Sensitive Drugs},
journal = {Pharmaceutics},
year = {2023},
volume = {15},
number = {1},
pages = {189},
doi = {10.3390/pharmaceutics15010189}
}
EUVIMED